{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:53:00Z","timestamp":1770144780814,"version":"3.49.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>\n                      Ischemia and reperfusion (IR) injury is a major complication in solid organ transplantation, necessitating new therapeutic strategies to suppress IR injury and thereby reduce early allograft dysfunction and delayed graft function. In kidney transplantation, IR injury is associated with disruption of mitochondrial homeostasis, including depletion of nicotinamide adenine dinucleotide (NAD\n                      <jats:sup>+<\/jats:sup>\n                      ) leading to diminished ATP levels, which cells need for survival. Here, we describe a novel approach to attenuate IR injury in a mouse kidney model using a NAD\n                      <jats:sup>+<\/jats:sup>\n                      -loaded nanoparticle, capable of direct intracellular delivery of NAD\n                      <jats:sup>+<\/jats:sup>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>\n                      C57BL\/6NCrl mice underwent a laparotomy and occlusion of the left renal pedicle for 30\u2009min to induce IR injury. Right nephrectomy was performed during the injury incubation. Mice received the test agents by 2 different techniques: direct kidney injection via the renal artery and systemically via intravenous (IV) injection into the vena cava. Mice received a single dose of the NAD\n                      <jats:sup>+<\/jats:sup>\n                      -loaded nanoparticle at 3 different concentrations. Blood and kidney tissue were collected for analysis 24\u2009h after IR injury. Measurement of blood creatinine levels and histological analysis was performed to assess the protective effectiveness of the NAD\n                      <jats:sup>+<\/jats:sup>\n                      -loaded nanoparticle.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      A single dose of NAD\n                      <jats:sup>+<\/jats:sup>\n                      -loaded nanoparticles resulted in significantly reduced creatinine levels in both the direct kidney-injected animals (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.0001) and the IV-injected animals (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.01) compared with empty nanoparticle, free NAD\n                      <jats:sup>+<\/jats:sup>\n                      , or saline controls. IR-induced renal tubular injury scores were markedly reduced for both IV delivery (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.01) and direct injection (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.05) compared with control treatments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>\n                      These results justify further development of this novel NAD\n                      <jats:sup>+<\/jats:sup>\n                      -loaded nanoparticle in the realm of organ transplantation to ameliorate IR injury and potentially increase usage of expanded criteria organs and reduce instances of delayed graft function.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/txd.0000000000001890","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T19:00:18Z","timestamp":1765393218000},"page":"e1890","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Attenuating Ischemia and Reperfusion Injury Using NAD+-Loaded Nanoparticles in Mouse Kidneys"],"prefix":"10.1097","volume":"12","author":[{"given":"Bret","family":"Verhoven","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, University of Wisconsin Institute for Discovery, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Chlebeck","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixiong","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."},{"name":"Pathology and Laboratory Medicine Service, William S. Middleton Memorial Veterans\u2019 Hospital, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weifeng","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Jennings","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Heise","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mia","family":"Levitsky","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruosen","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI."},{"name":"Wisconsin Institute for Discovery, University of Wisconsin, Madison, WI."},{"name":"McPherson Eye Research Institute, University of Wisconsin, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoqin","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI."},{"name":"Wisconsin Institute for Discovery, University of Wisconsin, Madison, WI."},{"name":"McPherson Eye Research Institute, University of Wisconsin, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4469-6375","authenticated-orcid":false,"given":"David P.","family":"Al-Adra","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"R1-20251210","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/TP.0000000000000450","article-title":"Center-level variation in the development of delayed graft function after deceased donor kidney transplantation.","volume":"99","author":"Orandi","year":"2015","journal-title":"Transplantation"},{"key":"R2-20251210","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/j.1600-6143.2010.03179.x","article-title":"A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation.","volume":"10","author":"Irish","year":"2010","journal-title":"Am J Transplant"},{"key":"R3-20251210","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.transproceed.2012.06.044","article-title":"Delayed graft function and long-term outcome in kidney transplantation.","volume":"44","author":"Grosso","year":"2012","journal-title":"Transplant Proc"},{"key":"R4-20251210","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/ajt.14018","article-title":"The changing financial landscape of renal transplant practice: a national cohort analysis.","volume":"17","author":"Axelrod","year":"2017","journal-title":"Am J Transplant"},{"key":"R5-20251210","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1111\/febs.17130","article-title":"Role of mitochondria in renal ischemia-reperfusion injury.","volume":"291","author":"Huang","year":"2024","journal-title":"FEBS J"},{"key":"R6-20251210","doi-asserted-by":"crossref","first-page":"244","DOI":"10.23876\/j.krcp.20.082","article-title":"Mitochondrial dysfunction in kidney injury, inflammation, and disease: potential therapeutic approaches.","volume":"39","author":"Bhatia","year":"2020","journal-title":"Kid Res Clin Pract"},{"key":"R7-20251210","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/nm.2507","article-title":"Ischemia and reperfusion\u2014from mechanism to translation.","volume":"17","author":"Eltzschig","year":"2011","journal-title":"Nat Med"},{"key":"R8-20251210","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrneph.2011.16","article-title":"Pathophysiology of ischemic acute kidney injury.","volume":"7","author":"Sharfuddin","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"R9-20251210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41420-024-01843-5","article-title":"Mitochondrial metabolism and targeted treatment strategies in ischemic-induced acute kidney injury.","volume":"10","author":"Chen","year":"2024","journal-title":"Cell Death Discov"},{"key":"R10-20251210","doi-asserted-by":"crossref","first-page":"101195","DOI":"10.1016\/j.molmet.2021.101195","article-title":"Role of NAD+ in regulating cellular and metabolic signaling pathways.","volume":"49","author":"Amjad","year":"2021","journal-title":"Mol Metab"},{"key":"R11-20251210","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/10409238.2015.1028612","article-title":"The human NAD metabolome: functions, metabolism and compartmentalization.","volume":"50","author":"Nikiforov","year":"2015","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"R12-20251210","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature17184","article-title":"PGC1\u03b1 drives NAD biosynthesis linking oxidative metabolism to renal protection.","volume":"531","author":"Tran","year":"2016","journal-title":"Nature"},{"key":"R13-20251210","doi-asserted-by":"crossref","first-page":"e0252554","DOI":"10.1371\/journal.pone.0252554","article-title":"Effect of NAD+ boosting on kidney ischemia-reperfusion injury.","volume":"16","author":"Morevati","year":"2021","journal-title":"PLoS One"},{"key":"R14-20251210","first-page":"3342","article-title":"Exogenous NAD(+) administration significantly protects against myocardial ischemia\/reperfusion injury in rat model.","volume":"8","author":"Zhang","year":"2016","journal-title":"Am J Transl Res"},{"key":"R15-20251210","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1007\/s12035-017-0809-7","article-title":"Combination of NAD+ and NADPH offers greater neuroprotection in ischemic stroke models by relieving metabolic stress.","volume":"55","author":"Huang","year":"2018","journal-title":"Mol Neurobiol"},{"key":"R16-20251210","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41565-022-01137-w","article-title":"NAD(H)-loaded nanoparticles for efficient sepsis therapy via modulating immune and vascular homeostasis.","volume":"17","author":"Ye","year":"2022","journal-title":"Nat Nanotechnol"},{"key":"R17-20251210","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jconrel.2024.10.045","article-title":"Targeted NAD+ repletion via biomimetic nanoparticle enables simultaneous management of intimal hyperplasia and accelerated re-endothelialization: a proof-of-concept study toward next-generation of endothelium-protective, anti-restenotic therapy.","volume":"376","author":"Yin","year":"2024","journal-title":"J Control Release"},{"key":"R18-20251210","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2011.10.020","article-title":"Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor.","volume":"158","author":"Li","year":"2012","journal-title":"J Control Release"},{"key":"R19-20251210","doi-asserted-by":"crossref","first-page":"F997","DOI":"10.1152\/ajprenal.00130.2004","article-title":"Endotoxemic acute renal failure is attenuated in caspase-1-deficient mice.","volume":"288","author":"Wang","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"R20-20251210","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1096\/fasebj.13.2.273","article-title":"Ligand-induced internalization of CD38 results in intracellular Ca2+ mobilization: role of NAD+ transport across cell membranes.","volume":"13","author":"Zocchi","year":"1999","journal-title":"FASEB J"},{"key":"R21-20251210","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1074\/jbc.M706204200","article-title":"Characterization of NAD uptake in mammalian cells.","volume":"283","author":"Billington","year":"2008","journal-title":"J Biol Chem"},{"key":"R22-20251210","doi-asserted-by":"crossref","first-page":"13103","DOI":"10.1038\/ncomms13103","article-title":"NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells.","volume":"7","author":"Ratajczak","year":"2016","journal-title":"Nat Commun"},{"key":"R23-20251210","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/antiox11050843","article-title":"Ex vivo lung perfusion with \u03b2-nicotinamide adenine dinucleotide (NAD+) improves ischemic lung function.","volume":"11","author":"Ehrsam","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"R24-20251210","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jconrel.2023.12.036","article-title":"Protein and peptide-based renal targeted drug delivery systems.","volume":"366","author":"Lu","year":"2024","journal-title":"J Control Release"},{"key":"R25-20251210","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.7150\/thno.37538","article-title":"Kidney-targeted rhein-loaded liponanoparticles for diabetic nephropathy therapy via size control and enhancement of renal cellular uptake.","volume":"9","author":"Wang","year":"2019","journal-title":"Theranostics"},{"key":"R26-20251210","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature15373","article-title":"Nanoparticle biointerfacing by platelet membrane cloaking.","volume":"526","author":"Hu","year":"2015","journal-title":"Nature"},{"key":"R27-20251210","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41581-019-0216-6","article-title":"NAD+ homeostasis in renal health and disease.","volume":"16","author":"Ralto","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"R28-20251210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/ijms24010137","article-title":"Roles of NAD+ in acute and chronic kidney diseases.","volume":"24","author":"Morevati","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R29-20251210","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000485663","article-title":"Renal PGC1\u03b1 may be associated with recovery after delayed graft function.","volume":"138","author":"Drury","year":"2018","journal-title":"Nephron"},{"key":"R30-20251210","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3390\/biom11071054","article-title":"Suppression of inflammation-associated kidney damage post-transplant using the New PrC-210 free radical scavenger in rats.","volume":"11","author":"Goesch","year":"2021","journal-title":"Biomolecules"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001890","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T19:00:22Z","timestamp":1765393222000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001890","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]}}}